Acute Myeloid Leukemia in A Young Adult: Diagnostic Insights from a Case Report
DOI:
https://doi.org/10.5195/ijms.2025.4062Keywords:
Acute Myeloid Leukemia, Young adult, Male, Flow cytometry, AdultAbstract
Background: Acute myeloid leukemia (AML) is a clonal hematopoietic stem cell disorder. It predominantly affects older adults and is characterized by the proliferation of immature myeloid cells and bone marrow failure. Diagnosis can be made using peripheral smear, cytochemistry, immunophenotyping, and cytogenetics, as early recognition is crucial for management and prognosis.
The Case: 21 year old male presented with fever, leukocytosis, mild anemia, and 75% of the blasts were medium-to-large size, with an irregular nuclear membrane, finely granular chromatin, nucleoli in peripheral blood smear with the presence of Auer rods, normocytic normochromic RBCs, and reduced platelets. Special stains such as myeloperoxidase (MPO) positivity, Sudan Black stain positivity, Periodic Acid-Schiff (PAS) negativity, and multicolor flow cytometry using CD45 vs. side scatter gating confirmed the diagnosis of Acute Myeloid Leukemia. Moreover, cytogenetic and molecular studies are recommended to improve prognosis and guide targeted therapy.
Conclusion: This case demonstrates how a thorough morphological evaluation and specific cytochemical tests can swiftly guide the diagnostic considerations for AML. Multicolor flow cytometry confirms lineage and facilitates the classification necessary for treatment planning. In young adults, where early intervention can significantly impact outcomes, combining traditional and modern diagnostic methods reduces the time to diagnosis and expedites referrals to the hematology/oncology department. This case underscores the ongoing educational and practical importance of peripheral smears and cytochemistry, especially in environments where immediate access to cytogenetic or molecular testing is limited.
Table 1. Immunophenotyping showing Myeloid Monocytic Markers Maturation Markers
CD34
Bright
Positive
CD13
Bright
Positive
CD33
Moderate
Positive
CD117
Moderate
Positive
CD64
Dim
Positive
HLA-DR
Dim
Positive
CD45
Dim
Positive
Downloads
Published
How to Cite
License
Copyright (c) 2025 Jainishkumar Morker, Dr. Pinal Shah, Dr. Mubin Patel, Dr. Rahul Modi, Dr. Deepshikha Dave, Dr. Krutika Patel

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org


